Digoxin Immune Fab labels and packages: Difference between revisions

Revision as of 17:12, 27 February 2014

Digoxin Immune Fab
DIGIFAB^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Digoxin Immune Fab
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information about Digoxin immune fab, click here.

Manufactured by: Protherics Inc. Brentwood, TN 37027

Distributed by: E. FOUGERA & CO. and Savage Laboratories®

                                             both divisions of Nycomed US Inc., Melville, NY 11747

U.S. License No. 1575

Revised: July 2008 IF7036510B

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 40 mg CONTAINER LABEL NDC 0281-0365-10

Digoxin Immune Fab (Ovine) Digifab®

40 mg

Rx Only

@@ Line 5: / Line 5: @@
 '''''For patient information about Digoxin immune fab, click [[Digoxin immune fab (patient information)|here]].'''''
-Manufactured by:                Protherics Inc.
+Manufactured by:                Protherics Inc. Brentwood, TN 37027
-                                               Brentwood, TN 37027
 Distributed by:                     E. FOUGERA & CO. and Savage Laboratories®
@@ Line 13: / Line 12: @@
 U.S. License No.                 1575
-Revised:                               July 2008
+Revised:                               July 2008 IF7036510B
-IF7036510B
 '''